Biodegradable nanoparticles for intracellular delivery of antimicrobial agents.

[1]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[2]  P. Bonventre,et al.  Killing of Intraphagocytic Staphylococcus aureus by Dihydrostreptomycin Entrapped Within Liposomes , 1978, Antimicrobial Agents and Chemotherapy.

[3]  C. Bucana,et al.  Biochemical, morphological, and ultrastructural studies on the uptake of liposomes by murine macrophages. , 1981, Cancer research.

[4]  S. G. Campbell,et al.  Liposome-encapsulated cephalothin in the treatment of experimental murine salmonellosis. , 1983, Journal of the Reticuloendothelial Society.

[5]  Desiderio Jv,et al.  Liposome-encapsulated cephalothin in the treatment of experimental murine salmonellosis. , 1983 .

[6]  S. G. Campbell,et al.  Intraphagocytic killing of Salmonella typhimurium by liposome-encapsulated cephalothin. , 1983, The Journal of infectious diseases.

[7]  M. Stevenson,et al.  Enhanced activity of streptomycin and chloramphenicol against intracellular Escherichia coli in the J774 macrophage cell line mediated by liposome delivery , 1983, Antimicrobial Agents and Chemotherapy.

[8]  R. Schwendener,et al.  The effects of charge and size on the interaction of unilamellar liposomes with macrophages. , 1984, Biochimica et biophysica acta.

[9]  V. Lenaerts,et al.  Degradation of poly (isobutyl cyanoacrylate) nanoparticles. , 1984, Biomaterials.

[10]  R. Lenk,et al.  Treatment of Brucella canis and Brucella abortus in vitro and in vivo by stable plurilamellar vesicle-encapsulated aminoglycosides. , 1985, The Journal of infectious diseases.

[11]  D. Papahadjopoulos,et al.  The effects of liposome size and surface charge on liposome-mediated delivery of methotrexate-gamma-aspartate to cells in vitro. , 1985, Biochimica et biophysica acta.

[12]  J. Crane,et al.  Uptake of ciprofloxacin by human neutrophils. , 1985, The Journal of antimicrobial chemotherapy.

[13]  C. Dees,et al.  Enhanced intraphagocytic killing of Brucella abortus in bovine mononuclear cells by liposomes-containing gentamicin. , 1985, Veterinary immunology and immunopathology.

[14]  M. Ito,et al.  Inhibitory effect of liposome-encapsulated penicillin G on growth of Listeria monocytogenes in mouse macrophages. , 1986, The Tohoku journal of experimental medicine.

[15]  C. Kirby,et al.  The effect of incorporation of cloxacillin in liposomes on treatment of experimental staphylococcal mastitis in mice. , 1986, Journal of veterinary pharmacology and therapeutics.

[16]  I. Bakker-Woudenberg,et al.  Effect of liposome-entrapped ampicillin on survival of Listeria monocytogenes in murine peritoneal macrophages , 1986, Antimicrobial Agents and Chemotherapy.

[17]  L. Bermudez,et al.  Intracellular killing of Mycobacterium avium complex by rifapentine and liposome-encapsulated amikacin. , 1987, The Journal of infectious diseases.

[18]  I. Bakker-Woudenberg,et al.  Effect of lipid composition on activity of liposome-entrapped ampicillin against intracellular Listeria monocytogenes , 1988, Antimicrobial Agents and Chemotherapy.

[19]  Y Ikada,et al.  Effect of the size and surface charge of polymer microspheres on their phagocytosis by macrophage. , 1988, Biomaterials.

[20]  P. Couvreur,et al.  Effectiveness of nanoparticle-bound ampicillin in the treatment of Listeria monocytogenes infection in athymic nude mice , 1988, Antimicrobial Agents and Chemotherapy.

[21]  J. Prescott,et al.  The use of liposomally-entrapped gentamicin in the treatment of bovine Staphylococcus aureus mastitis. , 1988, Canadian journal of veterinary research = Revue canadienne de recherche veterinaire.

[22]  I. Fidler,et al.  Targeting of immunomodulators to mononuclear phagocytes for therapy of cancer , 1988 .

[23]  M. Klempner,et al.  Interactions Between Antimicrobial Agents and Phagocytes , 1989 .

[24]  P. Couvreur,et al.  Treatment of experimental salmonellosis in mice with ampicillin-bound nanoparticles , 1989, Antimicrobial Agents and Chemotherapy.

[25]  P. Gangadharam,et al.  Differential effects of free and liposome encapsulated amikacin on the survival of Mycobacterium avium complex in mouse peritoneal macrophages. , 1990, Tubercle.

[26]  C. Dees,et al.  The mechanism of enhanced intraphagocytic killing of bacteria by liposomes containing antibiotics. , 1990, Veterinary immunology and immunopathology.

[27]  P. Tulkens,et al.  Cellular uptake, localization and activity of fluoroquinolones in uninfected and infected macrophages. , 1990, The Journal of antimicrobial chemotherapy.

[28]  L. Bermudez,et al.  Treatment of disseminated Mycobacterium avium complex infection of beige mice with liposome-encapsulated aminoglycosides. , 1990, The Journal of infectious diseases.

[29]  P. Couvreur,et al.  Liposome-entrapped ampicillin in the treatment of experimental murine listeriosis and salmonellosis , 1991, Antimicrobial Agents and Chemotherapy.

[30]  P. Gangadharam,et al.  Activity of free and liposome encapsulated streptomycin against Mycobacterium avium complex (MAC) inside peritoneal macrophages. , 1991, Journal of Antimicrobial Chemotherapy.

[31]  P. Couvreur,et al.  Ampicillin-loaded liposomes and nanoparticles: comparison of drug loading, drug release and in vitro antimicrobial activity. , 1991, Journal of microencapsulation.

[32]  P. Couvreur,et al.  Effect of nanoparticle-bound ampicillin on the survival of Listeria monocytogenes in mouse peritoneal macrophages. , 1992, The Journal of antimicrobial chemotherapy.

[33]  D. Papahadjopoulos,et al.  Recognition of liposomes by cells: in vitro binding and endocytosis mediated by specific lipid headgroups and surface charge density. , 1992, Biochimica et biophysica acta.

[34]  D. Friend,et al.  Efficacies of liposome-encapsulated streptomycin and ciprofloxacin against Mycobacterium avium-M. intracellulare complex infections in human peripheral blood monocyte/macrophages , 1992, Antimicrobial Agents and Chemotherapy.

[35]  P. Couvreur,et al.  Intracellular targeting of antibiotics by means of biodegradable nanoparticles , 1992 .

[36]  R. Müller,et al.  In vitro phagocytosis assay of nano- and microparticles by chemiluminescence. I. Effect of analytical parameters, particle size and particle concentration , 1992 .

[37]  D B Kell,et al.  Dormancy in non-sporulating bacteria. , 1993, FEMS microbiology reviews.

[38]  T. Kissel,et al.  Surface-modified biodegradable albumin nano- and microspheres. I: Preparation and characterization , 1993 .

[39]  A. Kresta,et al.  Distribution of Free and Liposome‐encapsulated Cefoxitin in Experimental Intra‐abdominal Sepsis in Rats , 1993, The Journal of pharmacy and pharmacology.

[40]  P. Couvreur,et al.  Development of a New Drug Carrier Made from Alginate. , 1993 .

[41]  R. Müller,et al.  In vitro phagocytosis assay of nano- and microparticles by chemiluminescence. II: Effect of surface modification by coating of particles with poloxamer on the phagocytic uptake , 1993 .

[42]  J. Krauss,et al.  Reconstitution of antibody-dependent phagocytosis in fibroblasts expressing Fc gamma receptor IIIB and the complement receptor type 3. , 1994, Journal of immunology.

[43]  C H Nightingale,et al.  Enhanced killing of methicillin-resistantStaphylococcus aureus in human macrophages by liposome-entrapped vancomycin and teicoplanin , 1994, Infection.

[44]  D. Nicolau,et al.  Activities of liposome-encapsulated azithromycin and rifabutin compared with that of clarithromycin against Mycobacterium avium-intracellulare complex in human macrophages. , 1994, International journal of antimicrobial agents.

[45]  P. Couvreur,et al.  The uptake of ampicillin-loaded nanoparticles by murine macrophages infected with Salmonella typhimurium. , 1994, Journal of Antimicrobial Chemotherapy.

[46]  L. Heifets,et al.  Effects of clarithromycin and rifabutin alone and in combination on intracellular and extracellular replication of Mycobacterium avium , 1994, Antimicrobial Agents and Chemotherapy.

[47]  D. Nicolau,et al.  Efficacies of liposome-encapsulated clarithromycin and ofloxacin against Mycobacterium avium-M. intracellulare complex in human macrophages , 1994, Antimicrobial Agents and Chemotherapy.

[48]  D. Scherman,et al.  A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[49]  U. Pleyer,et al.  Analysis of interactions between the corneal epithelium and liposomes: qualitative and quantitative fluorescence studies of a corneal epithelial cell line. , 1995, Survey of ophthalmology.

[50]  D. Nicolau,et al.  Activities of clarithromycin, azithromycin, and ofloxacin in combination with liposomal or unencapsulated granulocyte-macrophage colony-stimulating factor against intramacrophage Mycobacterium avium-Mycobacterium intracellulare. , 1995, The Journal of infectious diseases.

[51]  A. Rigotti,et al.  The Class B Scavenger Receptors SR-BI and CD36 Are Receptors for Anionic Phospholipids (*) , 1995, The Journal of Biological Chemistry.

[52]  V. Shepherd,et al.  Differential regulation of the mannose and SP-A receptors on macrophages. , 1995, The American journal of physiology.

[53]  M. Fresta,et al.  Intracellular accumulation of ofloxacin-loaded liposomes in human synovial fibroblasts , 1995, Antimicrobial agents and chemotherapy.

[54]  Y. Oh,et al.  Formulation and efficacy of liposome-encapsulated antibiotics for therapy of intracellular Mycobacterium avium infection , 1995, Antimicrobial agents and chemotherapy.

[55]  A. Vitas,et al.  Effect of composition and method of preparation of liposomes on their stability and interaction with murine monocytes infected with Brucella abortus , 1996, Antimicrobial agents and chemotherapy.

[56]  R. Hsia,et al.  Enhanced intramacrophage activity of resorcinomycin A against Mycobacterium avium-Mycobacterium intracellulare complex after liposome encapsulation , 1996, Antimicrobial agents and chemotherapy.

[57]  P. Gangadharam,et al.  Treatment of intracellular Mycobacterium avium complex infection by free and liposome-encapsulated sparfloxacin , 1996, Antimicrobial agents and chemotherapy.

[58]  P. Couvreur,et al.  Intracellular distribution of ampicillin in murine macrophages infected with Salmonella typhimurium and treated with (3H)ampicillin-loaded nanoparticles. , 1996, The Journal of antimicrobial chemotherapy.

[59]  P. Deol,et al.  Lung specific stealth liposomes: stability, biodistribution and toxicity of liposomal antitubercular drugs in mice. , 1997, Biochimica et biophysica acta.

[60]  Anderson,et al.  Biodegradation and biocompatibility of PLA and PLGA microspheres. , 1997, Advanced drug delivery reviews.

[61]  B. Finlay,et al.  Intracellular Delivery and Antibacterial Activity of Gentamicin Encapsulated in pH-Sensitive Liposomes , 1998, Antimicrobial Agents and Chemotherapy.

[62]  Qiang Zhang,et al.  Increase in gentamicin uptake by cultured mouse peritoneal macrophages and rat hepatocytes by its binding to polybutylcyanoacrylate nanoparticles , 1998 .

[63]  T. Steinberg,et al.  Size of IgG-opsonized particles determines macrophage response during internalization. , 1998, Experimental cell research.

[64]  D. Fischer,et al.  Surface-modified biodegradable albumin nano- and microspheres. II: effect of surface charges on in vitro phagocytosis and biodistribution in rats. , 1998, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[65]  G. Gregoriadis.  Targeting of drugs 6 : strategies for stealth therapeutic systems , 1998 .

[66]  M. Webb,et al.  Antibacterial Efficacy of Gentamicin Encapsulated in pH-Sensitive Liposomes against an In Vivo Salmonella enterica Serovar Typhimurium Intracellular Infection Model , 2000, Antimicrobial Agents and Chemotherapy.

[67]  P. Couvreur,et al.  Targeted delivery of antibiotics using liposomes and nanoparticles: research and applications. , 2000, International journal of antimicrobial agents.

[68]  R. Müller,et al.  Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[69]  L. Heifets,et al.  Nanoparticles as Antituberculosis Drugs Carriers: Effect on Activity Against Mycobacterium tuberculosis in Human Monocyte-Derived Macrophages , 2000 .

[70]  P. Low,et al.  Enhanced folate receptor mediated gene therapy using a novel pH-sensitive lipid formulation. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[71]  A. L. Baş,et al.  Efficacies of free and liposome-encapsulated enrofloxacin (Baytril®) against Staphylococcus aureus infection in Turkish Shepherd Dog neutrophils in vitro , 2000 .

[72]  G. Giammona,et al.  Amoxicillin-loaded polyethylcyanoacrylate nanoparticles: influence of PEG coating on the particle size, drug release rate and phagocytic uptake. , 2001, Biomaterials.

[73]  R. Schiffelers,et al.  Liposome-encapsulated aminoglycosides in pre-clinical and clinical studies. , 2001, The Journal of antimicrobial chemotherapy.

[74]  O. Bourdon,et al.  Relationship between complement activation, cellular uptake and surface physicochemical aspects of novel PEG-modified nanocapsules. , 2001, Biomaterials.

[75]  D. Raoult,et al.  Use of Aminoglycosides in Treatment of Infections Due to Intracellular Bacteria , 2001, Antimicrobial Agents and Chemotherapy.

[76]  L. Låstbom,et al.  Experimental and calculated parameters on particle phagocytosis by alveolar macrophages. , 2002, Journal of applied physiology.

[77]  K. Yanagihara.  Design of anti-bacterial drug and anti-mycobacterial drug for drug delivery system. , 2002, Current pharmaceutical design.

[78]  D. Portnoy,et al.  The cell biology of Listeria monocytogenes infection , 2002, The Journal of cell biology.

[79]  M. Çorlu,et al.  Determination of intracellular concentrations of free and two types of liposome-encapsulated enrofloxacin in anatolian shepherd dog monocytes. , 2002, Journal of veterinary medicine. B, Infectious diseases and veterinary public health.

[80]  V. Yardley,et al.  Toxicity and Antileishmanial Activity of a New Stable Lipid Suspension of Amphotericin B , 2003, Antimicrobial Agents and Chemotherapy.

[81]  N. Düzgüneş,et al.  Efficacies of cyclodextrin-complexed and liposome-encapsulated clarithromycin against Mycobacterium avium complex infection in human macrophages. , 2003, International journal of pharmaceutics.

[82]  Jayanth Panyam,et al.  Biodegradable nanoparticles for drug and gene delivery to cells and tissue. , 2003, Advanced drug delivery reviews.

[83]  I. Skidan,et al.  [Enhanced activity of rifampicin loaded with polybutyl cyanoacrylate nanoparticles in relation to intracellularly localized bacteria]. , 2003, Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic].

[84]  Zhengrong Cui,et al.  Physical Characterization and Macrophage Cell Uptake of Mannan-Coated Nanoparticles , 2003, Drug development and industrial pharmacy.

[85]  W. L. Hand.  Interactions Between Antimicrobial Agents, Phagocytic Cells and Bacteria , 2003 .

[86]  Sujatha Kannan,et al.  Drug complexation, in vitro release and cellular entry of dendrimers and hyperbranched polymers. , 2003, International journal of pharmaceutics.

[87]  Huiming Yang,et al.  Liposome delivery of ciprofloxacin against intracellular Francisella tularensis infection. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[88]  I. Zuhorn,et al.  Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. , 2004, The Biochemical journal.

[89]  Johnny Yang,et al.  The Characteristics and Mechanisms of Uptake of PLGA Nanoparticles in Rabbit Conjunctival Epithelial Cell Layers , 2004, Pharmaceutical Research.

[90]  Ruxandra Gref,et al.  Polysaccharide-decorated nanoparticles. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[91]  P. Couvreur,et al.  Liposomes and Nanoparticles in the Treatment of Intracellular Bacterial Infections , 1991, Pharmaceutical Research.

[92]  P. Couvreur,et al.  Intracellular Visualization of Ampicillin-Loaded Nanoparticles in Peritoneal Macrophages Infected in Vitro with Salmonella typhimurium , 2004, Pharmaceutical Research.

[93]  Sanyog Jain,et al.  Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophages. , 2004, International journal of pharmaceutics.

[94]  P. Couvreur,et al.  Polyalkylcyanoacrylate Nanoparticles as Polymeric Carriers for Antisense Oligonucleotides , 1992, Pharmaceutical Research.

[95]  P. Couvreur,et al.  Novel Polysaccharide-Decorated Poly(Isobutyl Cyanoacrylate) Nanoparticles , 2003, Pharmaceutical Research.

[96]  Gordon L. Amidon,et al.  The Mechanism of Uptake of Biodegradable Microparticles in Caco-2 Cells Is Size Dependent , 1997, Pharmaceutical Research.

[97]  R. Schiffelers,et al.  Host Factors Influencing the Preferential Localization of Sterically Stabilized Liposomes in Klebsiella Pneumoniae-Infected Rat Lung Tissue , 2004, Pharmaceutical Research.

[98]  D. Fischer,et al.  Recent advances in rational gene transfer vector design based on poly(ethylene imine) and its derivatives , 2005, The journal of gene medicine.

[99]  R. Pandey,et al.  Oral solid lipid nanoparticle-based antitubercular chemotherapy. , 2005, Tuberculosis.

[100]  C. Dees,et al.  Enhanced intracellular killing ofStaphylococcus aureus by canine monocytes treated with liposomes containing amikacin, gentamicin, kanamycin, and tobramycin , 1981, Current Microbiology.

[101]  N. Düzgüneş,et al.  Liposome-encapsulated antibiotics. , 2005, Methods in enzymology.

[102]  A. L. Baş,et al.  Efficacies of liposome-encapsulated enrofloxacin against Staphylococcus aureus infection in Anatolian shepherd dog monocytes in vitro. , 2005, DTW. Deutsche tierarztliche Wochenschrift.

[103]  A. Walubo,et al.  The effect of surface charge on the disposition of liposome-encapsulated gentamicin to the rat liver, brain, lungs and kidneys after intraperitoneal administration. , 2005, International journal of antimicrobial agents.

[104]  R. Pandey,et al.  Solid lipid particle-based inhalable sustained drug delivery system against experimental tuberculosis. , 2005, Tuberculosis.

[105]  Gert Storm,et al.  Long-circulating sterically stabilized liposomes in the treatment of infections. , 2005, Methods in enzymology.

[106]  F. Roerdink,et al.  Liposome-encapsulated ampicillin against Listeria monocytogenes in vivo and in vitro , 2005, Infection.

[107]  L. Yahia,et al.  Therapeutic potential of nanoparticulate systems for macrophage targeting. , 2005, Biomaterials.

[108]  C. Gamazo,et al.  Nanocarriers with gentamicin to treat intracellular pathogens. , 2006, Journal of nanoscience and nanotechnology.

[109]  Abhay Asthana,et al.  Intracellular macrophage uptake of rifampicin loaded mannosylated dendrimers , 2006, Journal of drug targeting.

[110]  Swarnlata Saraf,et al.  Nanocarriers: promising vehicle for bioactive drugs. , 2006, Biological & pharmaceutical bulletin.

[111]  C. Carbon.  Clinical relevance of intracellular and extracellular concentrations of macrolides , 2006, Infection.

[112]  P. Couvreur,et al.  Squalenoyl nanomedicines as potential therapeutics. , 2006, Nano letters.

[113]  J. Benoit,et al.  Evaluation of pegylated lipid nanocapsules versus complement system activation and macrophage uptake. , 2006, Journal of biomedical materials research. Part A.

[114]  O. Rozenberg,et al.  [Evaluation of the efficiency of activity of the liposomal form of isoniazid against different types of mycobacteria in vitro]. , 2006, Problemy tuberkuleza i boleznei legkikh.

[115]  D. Hoekstra,et al.  Cationic lipids, lipoplexes and intracellular delivery of genes. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[116]  T. Seki,et al.  Uptake characteristics of liposomes by rat alveolar macrophages: influence of particle size and surface mannose modification , 2007, The Journal of pharmacy and pharmacology.

[117]  K. Kisich,et al.  Encapsulation of moxifloxacin within poly(butyl cyanoacrylate) nanoparticles enhances efficacy against intracellular Mycobacterium tuberculosis. , 2007, International journal of pharmaceutics.

[118]  V. Labhasetwar,et al.  Biodegradable nanoparticles for cytosolic delivery of therapeutics. , 2007, Advanced drug delivery reviews.

[119]  Simon Benita,et al.  Targeting of nanoparticles to the clathrin-mediated endocytic pathway. , 2007, Biochemical and biophysical research communications.

[120]  Cheol Moon,et al.  In vitro assessment of a novel polyrotaxane-based drug delivery system integrated with a cell-penetrating peptide. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[121]  Justin Hanes,et al.  Privileged delivery of polymer nanoparticles to the perinuclear region of live cells via a non-clathrin, non-degradative pathway. , 2007, Biomaterials.

[122]  T. Seki,et al.  Efficient drug targeting to rat alveolar macrophages by pulmonary administration of ciprofloxacin incorporated into mannosylated liposomes for treatment of respiratory intracellular parasitic infections. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[123]  D. Lim,et al.  Glyconanobiotics: Novel carbohydrated nanoparticle antibiotics for MRSA and Bacillus anthracis. , 2008, Bioorganic & medicinal chemistry.

[124]  I. I. Lyubimov,et al.  Development of a nanosomal formulation of moxifloxacin based on poly(butyl-2-cyanoacrylate) , 2008, Pharmaceutical Chemistry Journal.

[125]  T. Seki,et al.  Efficient Drug Delivery to Alveolar Macrophages and Lung Epithelial Lining Fluid Following Pulmonary Administration of Liposomal Ciprofloxacin in Rats with Pneumonia and Estimation of its Antibacterial Effects , 2008, Drug development and industrial pharmacy.

[126]  Hamidreza Ghandehari,et al.  Endocytosis inhibitors prevent poly(amidoamine) dendrimer internalization and permeability across Caco-2 cells. , 2008, Molecular pharmaceutics.

[127]  J. M. Lanao,et al.  Delivery systems to increase the selectivity of antibiotics in phagocytic cells. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[128]  S. Kawakami,et al.  Efficient targeting to alveolar macrophages by intratracheal administration of mannosylated liposomes in rats. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[129]  V. Labhasetwar,et al.  Quantification of the force of nanoparticle-cell membrane interactions and its influence on intracellular trafficking of nanoparticles. , 2008, Biomaterials.

[130]  Ashish Ranjan,et al.  Targeting Brucella melitensis with polymeric nanoparticles containing streptomycin and doxycycline. , 2009, FEMS microbiology letters.

[131]  J. Riffle,et al.  In Vitro Trafficking and Efficacy of Core-Shell Nanostructures for Treating Intracellular Salmonella Infections , 2009, Antimicrobial Agents and Chemotherapy.

[132]  A. Fadda,et al.  Rifampicin-loaded liposomes for the passive targeting to alveolar macrophages: in vitro and in vivo evaluation , 2009, Journal of liposome research.

[133]  J. Riffle,et al.  Antibacterial efficacy of core-shell nanostructures encapsulating gentamicin against an in vivo intracellular Salmonella model , 2009, International journal of nanomedicine.

[134]  T. Srichana,et al.  Monitoring safety of liposomes containing rifampicin on respiratory cell lines and in vitro efficacy against Mycobacterium bovis in alveolar macrophages , 2009, Journal of drug targeting.

[135]  A. Tedesco,et al.  In vitrouptake and antimycobacterial activity of liposomal usnic acid formulation , 2009, Journal of liposome research.

[136]  P. Couvreur,et al.  Nanocarriers’ entry into the cell: relevance to drug delivery , 2009, Cellular and Molecular Life Sciences.

[137]  S. Chakraborty,et al.  Nanoconjugated vancomycin: new opportunities for the development of anti-VRSA agents , 2010, Nanotechnology.

[138]  Z. Drulis-Kawa,et al.  Liposomes as delivery systems for antibiotics. , 2010, International journal of pharmaceutics.

[139]  C. Gamazo,et al.  Drug delivery systems for potential treatment of intracellular bacterial infections. , 2010, Frontiers in bioscience.

[140]  M. Seleem,et al.  Efficacy of Amphiphilic Core-Shell Nanostructures Encapsulating Gentamicin in an In Vitro Salmonella and Listeria Intracellular Infection Model , 2010, Antimicrobial Agents and Chemotherapy.

[141]  Gaurav Sahay,et al.  Endocytosis of nanomedicines. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[142]  P. Bora,et al.  Relationship Between Complement Activation and Choroidal Neovascularization in Type II Diabetes , 2010 .

[143]  H. Gérard,et al.  PAMAM dendrimer-azithromycin conjugate nanodevices for the treatment of Chlamydia trachomatis infections. , 2011, Nanomedicine : nanotechnology, biology, and medicine.

[144]  G. Betageri,et al.  PEGylated Liposome Encapsulation Increases the Lung Tissue Concentration of Vancomycin , 2011, Antimicrobial Agents and Chemotherapy.

[145]  G. Betageri,et al.  Preparation of liposomal vancomycin and intracellular killing of meticillin-resistant Staphylococcus aureus (MRSA). , 2011, International journal of antimicrobial agents.

[146]  Kenneth Vecchio,et al.  Bacterial toxin-triggered drug release from gold nanoparticle-stabilized liposomes for the treatment of bacterial infection. , 2011, Journal of the American Chemical Society.

[147]  R. Kannan,et al.  Poly(amidoamine) dendrimer-erythromycin conjugates for drug delivery to macrophages involved in periprosthetic inflammation. , 2011, Nanomedicine : nanotechnology, biology, and medicine.

[148]  P. Couvreur,et al.  Self-assembled squalenoylated penicillin bioconjugates: an original approach for the treatment of intracellular infections. , 2012, ACS nano.

[149]  Ruth Duncan,et al.  Endocytosis and intracellular trafficking as gateways for nanomedicine delivery: opportunities and challenges. , 2012, Molecular pharmaceutics.

[150]  S. Nair,et al.  Efficacy of tetracycline encapsulated O-carboxymethyl chitosan nanoparticles against intracellular infections of Staphylococcus aureus. , 2012, International journal of biological macromolecules.

[151]  T. Lu,et al.  Surface charge-switching polymeric nanoparticles for bacterial cell wall-targeted delivery of antibiotics. , 2012, ACS nano.

[152]  S. Boyle,et al.  Nanomedicine for intracellular therapy. , 2012, FEMS microbiology letters.

[153]  Jun Wang,et al.  Lipase-sensitive polymeric triple-layered nanogel for "on-demand" drug delivery. , 2012, Journal of the American Chemical Society.

[154]  I. H. Bechtold,et al.  An Isoniazid Analogue Promotes Mycobacterium tuberculosis-Nanoparticle Interactions and Enhances Bacterial Killing by Macrophages , 2012, Antimicrobial Agents and Chemotherapy.

[155]  J. Veciana,et al.  Cellular pharmacokinetics and intracellular activity against Listeria monocytogenes and Staphylococcus aureus of chemically modified and nanoencapsulated gentamicin. , 2012, The Journal of antimicrobial chemotherapy.

[156]  Enhanced Antibacterial Effect of Ceftriaxone Sodium-Loaded Chitosan Nanoparticles Against Intracellular Salmonella typhimurium , 2012, AAPS PharmSciTech.

[157]  Richey M. Davis,et al.  Block ionomer complexes containing cationic antibiotics to kill intracellular Brucella melitensis in vitro , 2012 .

[158]  Yoshitake Masuda,et al.  α-Fe2O3ナノ構造体の形状制御合成:改良した光触媒分解効率のための表面特性の加工 , 2013 .

[159]  D. Chakravortty,et al.  Chitosan-dextran sulphate nanocapsule drug delivery system as an effective therapeutic against intraphagosomal pathogen Salmonella. , 2013, The Journal of antimicrobial chemotherapy.

[160]  Adam J Friedman,et al.  Nanotechnology as a therapeutic tool to combat microbial resistance. , 2013, Advanced drug delivery reviews.

[161]  B. Sarmento,et al.  Hydrolyzed galactomannan-modified nanoparticles and flower-like polymeric micelles for the active targeting of rifampicin to macrophages. , 2013, Journal of biomedical nanotechnology.

[162]  Giuseppe Battaglia,et al.  Polymersome‐mediated intracellular delivery of antibiotics to treat Porphyromonas gingivalis‐infected oral epithelial cells , 2013, The FASEB Journal.

[163]  A. Pardakhty,et al.  Ciprofloxacin nano-niosomes for targeting intracellular infections: an in vitro evaluation , 2013, Journal of nanoparticle research.